B12 deficiency causes fatigue, brain fog, and nerve damage
Safety history: pancreatitis, gallbladder disease, kidney disease, or thyroid cancer risk
5,18 Empagliflozin is not recommended for use in patients with an eGFR of less than 20 mL/min/1.73 m 2 and dapagliflozin is not recommended for patients with an eGFR of less than 25 mL/min/1.73 m 2
which will allow hospital systems, ambulatory care centers, and other healthcare organizations to make informed decisions in the interest of patient safety, medication effectiveness, and consumer satisfaction
But if severe, they can make you lose more fluids than usual, which can lead to dehydration
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis